BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
glucose metabolic process
,
HIV infection
,
Retina
,
Biofuel
,
Rapamycin
,
rs2300478
,
CYP51
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fancd2 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Chronic myeloid leukemias with BCR-ABL fusions before and after imatinib mesylate treatment
Embryonic kidney HEK293T cells with CRISPR-mediated RBBP8 knockout
Cervical cancer primary biopsies prospectively linked to cisplatin/radiation therapy response
Explore Curated Studies Results
Literature
Most Relevant Literature
FANCD2 promotes the malignant behavior of endometrial cancer cells and its prognostic value.
Structural and biochemical basis of interdependent FANCI-FANCD2 ubiquitination.
Phosphorylation by ATR triggers FANCD2 chromatin loading and activates the Fanconi anemia pathway.
Mechanism, specificity, and function of FANCD2-FANCI ubiquitination and deubiquitination.
Differential operation of MLH1/MSH2 and FANCD2 crosstalk in chemotolerant bladder carcinoma: a clini…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nivolumab and Veliparib in Treating Patients With Recurrent or Refractory Stage IV Solid Tumors That…
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have…
Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer
A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematologica…
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ